ResearcherHarbin Medical UniversityNo recent work listed

Xiaoyi Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-1636-0214; OpenAlex author ID A5101278481. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper

Papers 1

Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fonc.2022.992929 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuanlong Gu · 1 shared paper, 2022 · strength 0.15
- Paper Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2022.992929 ↗
Juan Zhao · 1 shared paper, 2022 · strength 0.15
- Paper Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma. DOI 10.3389/fonc.2022.992929 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.